Celularity Inc. Files 2024 Annual Report Amendment
Ticker: CELUW · Form: 10-K/A · Filed: May 21, 2025 · CIK: 1752828
Sentiment: neutral
Topics: amendment, annual-report, pharmaceuticals
Related Tickers: CELU
TL;DR
Celularity filed its 2024 10-K amendment on 5/21/25. Check it for updated financials.
AI Summary
Celularity Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, formerly GX Acquisition Corp., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector. The filing was made on May 21, 2025, and its principal business address is in Florham Park, NJ.
Why It Matters
This amendment provides updated financial and operational information for Celularity Inc. for the 2024 fiscal year, which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Celularity faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the annual report.)
- 2025-05-21 — Filing Date (The date the amendment was submitted to the SEC.)
Key Players & Entities
- Celularity Inc. (company) — Registrant
- GX Acquisition Corp. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 20250521 (date) — Filing date
- 001-38914 (company) — SEC file number
- Florham Park, NJ (location) — Business address
FAQ
What is the primary purpose of this 10-K/A filing?
This filing is an amendment to Celularity Inc.'s annual report for the fiscal year ended December 31, 2024, providing updated information.
What was Celularity Inc.'s former company name?
Celularity Inc.'s former company name was GX Acquisition Corp.
In which state is Celularity Inc. incorporated?
Celularity Inc. is incorporated in Delaware.
What is Celularity Inc.'s Standard Industrial Classification (SIC) code?
Celularity Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
When was this amendment filed with the SEC?
This amendment was filed with the SEC on May 21, 2025.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on May 21, 2025 regarding Celularity Inc (CELUW).